Ignelzi Troy A.insider trades

In SEC Form 4 filings, Ignelzi Troy A. is listed as Chief Financial Officer of Rapport Therapeutics, Inc. (RAPP). In the last 90 days, Ignelzi Troy A. bought $143.6K of Rapport Therapeutics, Inc. (RAPP) on the open market and sold none. The purchase was $143.6K of Rapport Therapeutics, Inc. (RAPP) on Oct 21. Took part in a cluster buy; the latest at Rapport Therapeutics, Inc. (RAPP), where 6 insiders bought within 3 days, ending Oct 23.

Companies and roles

Company	Role	Transactions	Last filed
RAPPRapport Therapeutics, Inc.	Chief Financial Officer	1	Oct 21

Cluster buys

RAPP: 6 insiders bought $1.66M between Oct 21 – Oct 23.

Form 4 historysince 2026-10-21

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
RAPPRapport Therapeutics, Inc.	Oct 21	Oct 21	P	5,500	$26.10	Purchase +$143,550	15,500	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.